Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.050.166 |
Chemical and physical data | |
Formula | C8H10N4O2 |
Molar mass | 194.194 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Enprofylline (3-propylxanthine) is a xanthine derivative used in the treatment of asthma, which acts as a bronchodilator. It acts primarily as a competitive nonselective phosphodiesterase inhibitor with relatively little activity as a nonselective adenosine receptor antagonist.[1][2]
| |
---|---|
PDE1 |
|
PDE2 |
|
PDE3 |
|
PDE4 |
|
PDE5 |
|
PDE7 |
|
PDE9 |
|
PDE10 |
|
PDE11 | |
Non-selective |
|
Unsorted |
|
See also: Receptor/signaling modulators |
| |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Receptor (ligands) |
| ||||||||||
Transporter (blockers) |
| ||||||||||
Enzyme (inhibitors) |
| ||||||||||
Others |
| ||||||||||
See also: Receptor/signaling modulators |